You are in : Home » Results & submissions » Select UOA » 1 - Clinical Medicine » View submission: University of Plymouth » Outputs » Detail

Output details

1 - Clinical Medicine

University of Plymouth

Return to search Previous output Next output

Output 13 of 60 in the submission

Article title

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial

Type

D - Journal article

DOI

10.1016/S1470-2045(11)70150-4

Title of journal

LANCET ONCOLOGY

Article number

Volume number

Issue number

First page of article

773

ISSN of journal

1470-2045

Year of publication

2011

URL

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000293272100028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008

Number of additional authors

Additional information

The author made a substantial contribution to the conception and design of the study and carrying out the study (including acquisition of study). The author helped draft the output.

Interdisciplinary

Cross-referral requested

Research group

None

Citation count

Proposed double-weighted

Double-weighted statement

Reserve for a double-weighted output

Non-English

English abstract